bf/AMEX:RMED_icon.jpeg

AMEX:RMED

Ra Medical Systems, Inc.

  • Stock

USD

Last Close

0.54

17/08 20:00

Market Cap

3.84M

Beta: -

Volume Today

74.50K

Avg: 72.73K

PE Ratio

−0.02

PFCF: −0.15

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
1.03M
-
1.65M
59.39%
2.44M
48.01%
2.50M
2.48%
1.60M
35.86%
519.20K
67.59%
average payables
449.50K
-
775.50K
72.53%
1.33M
71.31%
1.05M
20.85%
779.50K
25.87%
540K
30.72%
average receivables
455K
-
918.50K
101.87%
1.05M
14.64%
512K
51.38%
129.50K
74.71%
48.29K
62.71%
book value per share
-39.24
-
-786.43
1,903.95%
9.03K
1,248.70%
3.15K
65.10%
622.34
80.26%
135.38
78.25%
8.96
93.38%
capex per share
-21.69
-
-56.49
160.48%
-78.82
39.53%
-25.48
67.67%
-1.97
92.26%
-2.62
33.07%
-0.02
99.37%
capex to depreciation
-2.21
-
-2.51
13.51%
-0.93
62.83%
-0.15
83.58%
-0.03
81.50%
-0.17
497.71%
-0.04
76.15%
capex to operating cash flow
0.11
-
0.10
11.05%
0.03
68.25%
0.01
74.31%
0.00
70.70%
0.01
305.24%
0.00
92.15%
capex to revenue
-0.04
-
-0.09
165.18%
-0.09
0.18%
-0.04
59.98%
-0.02
59.14%
-12.05
79,094.37%
-1.21
89.92%
cash per share
404.94
-
850.67
110.07%
8.71K
923.91%
2.91K
66.62%
703.53
75.80%
148.96
78.83%
15.34
89.70%
days of inventory on hand
101.20
-
104.81
3.57%
181.98
73.63%
114.53
37.06%
147.68
28.94%
230.70
56.22%
118.81
48.50%
days payables outstanding
55.02
-
37.33
32.14%
97.63
161.51%
63.18
35.28%
38.02
39.83%
231.17
508.04%
208.57
9.77%
days sales outstanding
24.00
-
32.15
33.93%
77.00
139.53%
39.85
48.25%
19.72
50.51%
348.41
1,666.71%
1.97K
465.61%
debt to assets
0.02
-
0.01
69.48%
0.01
105.37%
0.08
590.78%
0.15
84.21%
0.11
26.36%
0.01
93.14%
debt to equity
-0.28
-
-0.01
97.06%
0.01
254.02%
0.11
727.61%
0.23
119.04%
0.17
28.32%
0.01
91.90%
dividend yield
0.00
-
0.15
-
earnings yield
-0.02
-
-0.07
322.77%
-0.42
472.56%
-3.83
812.59%
-2.86
25.53%
-3.46
21.19%
-4.41
27.48%
enterprise value
238.26M
-
233.90M
1.83%
9.91M
95.76%
3.77M
62.01%
-6.40M
269.88%
-4.90M
23.36%
-9.64M
96.71%
enterprise value over ebitda
-58.07
-
-13.33
77.04%
-0.32
97.61%
-0.07
79.50%
0.18
371.98%
0.17
5.57%
0.53
216.38%
ev to operating cash flow
-126.33
-
-42.35
66.48%
-0.54
98.74%
-0.11
78.81%
0.23
299.10%
0.18
21.48%
0.43
140.79%
ev to sales
39.87
-
39.85
0.06%
1.58
96.02%
0.52
66.98%
-1.45
377.63%
-222.86
15,245.45%
-688.90
209.11%
free cash flow per share
-216.46
-
-626.87
189.60%
-2.59K
312.42%
-3.18K
23.00%
-834.93
73.74%
-276.14
66.93%
-21.84
92.09%
free cash flow yield
-0.01
-
-0.03
189.60%
-0.26
937.52%
-2.25
765.37%
-2.25
0.17%
-3.54
57.52%
-3.71
4.75%
graham net net
-162.27
-
-997.75
514.88%
7.99K
901.14%
2.06K
74.28%
379.71
81.53%
81.02
78.66%
8.09
90.01%
graham number
619.01
-
5.70K
820.44%
29.13K
411.31%
19.60K
32.72%
3.85K
80.34%
906.72
76.47%
72.36
92.02%
income quality
0.45
-
0.31
30.73%
0.60
93.08%
0.58
2.98%
0.79
34.82%
1.10
40.33%
0.84
23.76%
intangibles to total assets
0
-
0
0
0
0
0
2.20
Infinity%
interest coverage
-1.40K
-
-4.44K
217.29%
-2.23K
49.87%
-230.92
89.62%
-333.88
44.59%
-8.76
-
interest debt per share
11.36
-
6.92
39.09%
117.01
1,591.05%
356.22
204.44%
146.94
58.75%
22.42
84.74%
3.10
86.19%
inventory turnover
3.61
-
3.48
3.45%
2.01
42.40%
3.19
58.89%
2.47
22.44%
1.58
35.99%
3.07
94.17%
invested capital
-0.28
-
-0.01
97.06%
0.01
254.02%
0.11
727.61%
0.23
119.04%
0.17
28.32%
0.01
91.90%
market cap
242.07M
-
242.07M
0%
73.38M
69.69%
14.85M
79.76%
12.62M
15.01%
7.88M
37.59%
6.09M
22.69%
net current asset value
-914K
-
-8.84M
867.40%
61.90M
800.10%
25.07M
59.50%
15.33M
38.85%
9.72M
36.60%
9.26M
4.71%
net debt to ebitda
0.93
-
0.47
49.87%
2.04
337.10%
0.19
90.57%
0.53
174.64%
0.44
17.21%
0.86
98.01%
net income per share
-433.96
-
-1.83K
322.77%
-4.18K
127.59%
-5.42K
29.71%
-1.06K
80.41%
-269.91
74.56%
-25.98
90.37%
operating cash flow per share
-194.77
-
-570.38
192.84%
-2.51K
339.44%
-3.15K
25.85%
-832.96
73.59%
-273.51
67.16%
-21.83
92.02%
payables turnover
6.63
-
9.78
47.37%
3.74
61.76%
5.78
54.51%
9.60
66.20%
1.58
83.55%
1.75
10.83%
receivables turnover
15.21
-
11.35
25.33%
4.74
58.25%
9.16
93.22%
18.51
102.08%
1.05
94.34%
0.19
82.32%
research and ddevelopement to revenue
0.29
-
0.77
168.20%
0.44
42.36%
0.63
41.83%
2.04
224.98%
556.95
27,135.62%
456.57
18.02%
return on tangible assets
-0.72
-
-1.58
119.17%
-0.42
73.58%
-1.29
210.26%
-1.08
16.57%
-1.30
20.17%
1.33
202.85%
revenue per share
617.16
-
606.22
1.77%
847.37
39.78%
684.58
19.21%
129.64
81.06%
0.22
99.83%
0.01
93.78%
roe
11.06
-
2.33
78.90%
-0.46
119.81%
-1.72
271.72%
-1.70
0.80%
-1.99
16.97%
-2.90
45.51%
roic
15.38
-
2.35
84.71%
-0.46
119.62%
-1.46
216.17%
-1.26
13.71%
-1.61
27.76%
-2.84
76.34%
sales general and administrative to revenue
4.86
-
159.50
-
shareholders equity per share
-39.24
-
-786.43
1,903.95%
9.03K
1,248.70%
3.15K
65.10%
622.34
80.26%
135.38
78.25%
8.96
93.38%
stock based compensation to revenue
0.38
-
2.16
462.41%
2.35
8.74%
3.27
38.94%
0.93
71.66%
101.68
10,872.77%
31.93
68.60%
tangible asset value
-380K
-
-7.62M
1,903.95%
66.70M
975.97%
33.15M
50.30%
21.15M
36.21%
13.67M
35.34%
-27.74M
302.88%
tangible book value per share
-39.24
-
-786.43
1,903.95%
9.03K
1,248.70%
3.15K
65.10%
622.34
80.26%
135.38
78.25%
-26.83
119.82%
working capital
2.60M
-
7.41M
185.18%
63.28M
754.14%
29.19M
53.88%
19.86M
31.96%
11.70M
41.09%
9.26M
20.85%

All numbers in USD (except ratios and percentages)